Tag Archives: Treatment

Many people living with HIV unwilling to interrupt treatment for prolonged periods during HIV cure trials

A study assessing the opinions of people living with HIV and their healthcare providers about analytic treatment interruptions (ATIs) has found that patients had limited understanding of how ATIs are usually conducted in HIV cure studies. These findings are reported by Dr Jillian Lau and colleagues in AIDS Research and Retroviruses. Treatment interruptions pose potential… Read More »

FDA Approves Xcopri (cenobamate) for the Treatment of Partial-Onset Seizures in Adults

FDA Approves Xcopri (cenobamate) for the Treatment of Partial-Onset Seizures in Adults Print this page PANGYO, South Korea and PARAMUS, N.J., Nov. 21, 2019 /PRNewswire/ — SK Biopharmaceuticals, Co., Ltd., an innovative global pharmaceutical company focused on developing and bringing treatments to market for central nervous system (CNS) disorders, and its U.S. subsidiary SK Life… Read More »

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions Print this page SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the U.S. Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the… Read More »

Palforzia, If Approved For Peanut Allergy, May Widen Access To A Known Treatment : Shots – Health News – NPR

Enlarge this image Palforzia, a new drug to treat peanut allergies, is expected to get FDA approval. The main ingredient of the drug is peanut flour. Marco Livolsi/EyeEm/Getty Images hide caption toggle caption Marco Livolsi/EyeEm/Getty Images A panel of experts earlier this month recommended that the U.S. Food and Drug Administration approve a new drug… Read More »